Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2026-04-14 @ 4:37 PM
Study NCT ID:
NCT06176027
Status:
RECRUITING
Last Update Posted:
2024-10-29
First Post:
2023-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas
Sponsor:
Navy General Hospital, Beijing
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NavyGHB-008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |